Envista (NYSE:NVST) Stock Breaks Below Fifty Day Moving Average – Here’s What Happened

01 Nov 2026, 15:20 by Danessa Lincoln · The Markets Daily

Envista Holdings Corporation (NYSE:NVST – Get Free Report) shares passed below its 50-day moving average during trading on Friday. The stock has a 50-day moving average of $24.59 and traded as low as $23.40. Envista shares last traded at $23.48, with a volume of 3,727,983 shares traded.

Wall Street Analyst Weigh In

A number of research firms have commented on NVST. Morgan Stanley set a $23.00 price objective on shares of Envista in a report on Thursday, August 6th. Weiss Ratings raised shares of Envista from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, August 6th. Mizuho set a $29.00 price target on shares of Envista in a research report on Thursday, August 6th. Needham & Company LLC restated a “hold” rating on shares of Envista in a research report on Friday, September 18th. Finally, Deutsche Bank Aktiengesellschaft set a $32.00 price target on shares of Envista in a report on Thursday, September 3rd. Six equities research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $28.86.

Get Our Latest Research Report on Envista

Envista Stock Down 4.6%

The firm has a market cap of $3.77 billion, a price-to-earnings ratio of 40.48, a price-to-earnings-growth ratio of 1.20 and a beta of 0.89. The company has a current ratio of 2.43, a quick ratio of 2.07 and a debt-to-equity ratio of 0.47. The stock has a 50-day moving average of $24.59 and a 200-day moving average of $25.71.

Envista (NYSE:NVST – Get Free Report) last issued its earnings results on Wednesday, August 5th. The company reported $0.41 earnings per share for the quarter, topping the consensus estimate of $0.34 by $0.07. Envista had a return on equity of 7.88% and a net margin of 3.33%. The firm had revenue of $730.50 million for the quarter, compared to analyst estimates of $716.11 million. During the same period last year, the company earned $0.26 earnings per share. The firm’s revenue for the quarter was up 7.1% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. As a group, sell-side analysts forecast that Envista Holdings Corporation will post 1.53 EPS for the current fiscal year.

Insider Buying and Selling at Envista

In related news, SVP Mischa Reis sold 8,000 shares of the stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $27.50, for a total value of $220,000.00. Following the sale, the senior vice president owned 27,321 shares of the company’s stock, valued at $751,327.50. This trade represents a 22.65% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.99% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in shares of Envista during the second quarter valued at approximately $25,000. Provenance Wealth Advisors LLC acquired a new position in shares of Envista during the third quarter worth approximately $28,000. Nisa Investment Advisors LLC boosted its position in shares of Envista by 116.4% during the third quarter. Nisa Investment Advisors LLC now owns 1,679 shares of the company’s stock worth $39,000 after buying an additional 903 shares during the period. Nykredit A S acquired a new position in shares of Envista during the second quarter worth approximately $52,000. Finally, Elevation Wealth Partners LLC grew its holdings in Envista by 262.9% in the 3rd quarter. Elevation Wealth Partners LLC now owns 2,406 shares of the company’s stock worth $56,000 after buying an additional 1,743 shares in the last quarter.

Envista Company Profile

(Get Free Report)

Envista Holdings Corporation (NYSE: NVST) is a global dental products and technologies company headquartered in Brea, California. The company develops, manufactures and markets products used by dentists, dental specialists, dental laboratories and other oral health professionals.

Envista’s portfolio includes dental implants, orthodontic systems, digital imaging and workflow solutions, dental consumables, treatment equipment and related technologies. Its brands include Nobel Biocare, Ormco, DEXIS and Kerr, which provide products and services spanning implant dentistry, orthodontics, diagnostic imaging, restorative care and general dental practice management.